U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD

Non-Invasive, Self-Neuromodulation, Adjunct to Standard of Care Therapy Using Amygdala Derived EEG-fMRI Pattern Biomarkers to Help Patients with PTSD HAIFA, Israel, March 21, 2023 -- (Healthcare Sales & Marketing Network) -- GrayMatters Health (GMH), d... Devices, Neurology, FDA GrayMatters Health, self-neuromodulation, PTSD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news